{"id":"W4411884054","doi":"10.3899/jrheum.2025-0314.110","title":"Improvements in BILAG Musculoskeletal and Mucocutaneous Domains at Week 48 in a Phase 2 Double-Blind Placebo-Controlled Trial of ABBV-599 (Elsubrutinib + Upadacitinib Combination) and Upadacitinib Monotherapy for Treatment of Moderately to Severely Active Systemic Lupus Erythematosus","year":2025,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Placebo; Interim analysis; Urology; Internal medicine; Post-hoc analysis; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001415549,0.00159011,0.002309734,0.0004513057,0.0004129063,0.000832091,0.0006984354,0.00149482,0.007309173],"category_scores_gemma":[0.001108005,0.0007238479,0.001282324,0.0002713442,0.0008082318,0.0009377577,0.000375683,0.00231007,0.0009969833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004339787,"about_ca_system_score_gemma":0.0006825409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003948179,"about_ca_topic_score_gemma":0.001145286,"domain_scores_codex":[0.9993388,0.0002854615,0.00004987093,0.0001560026,0.00005194834,0.0001178405],"domain_scores_gemma":[0.9994369,0.000116032,0.0001332788,0.00004668064,0.00004357484,0.0002234124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9696215,0.01286767,0.0004225873,0.0003337167,0.0003308194,0.00002553254,0.00002850293,0.0001989469,0.005948531,0.00004804283,0.0004282352,0.009745952],"study_design_scores_gemma":[0.9053181,0.09026993,0.002564925,0.00001519897,0.0002311577,0.00002485414,0.00001271039,0.0003640606,0.0008186041,0.00007455001,0.0002918834,0.00001398922],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920149,0.001811817,0.0004713308,0.0002611941,0.0003428296,0.002530329,0.000795791,0.0001254157,0.001646436],"genre_scores_gemma":[0.991581,0.0008029167,0.0008845647,0.000410141,0.0002014193,0.003017158,0.0007600297,0.00002012656,0.002322623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007309173,"threshold_uncertainty_score":0.02445161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02643527223498299,"score_gpt":0.3486359100565005,"score_spread":0.3222006378215175,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}